Interventional Pulmonology

Roberto de Barros Silva

University of São Paulo

Brazil

Academic Editor

Biography

He is currently a professor in the Medicine course at the Bahiana School of Medicine and Public Health (BAHIANA), Salvador - BA, teaching Pharmacology. He was a lecturer in the medicine course at Unifacs from 2018 to 2024, at FTC/Zarns (2022-2024), and at UNIME in Lauro de Freitas, Bahia. He was also a member of the research ethics committee of the nutrition school at the Federal University of Bahia (UFBA) from 2019 to 2020. Recently, he was approved in the REDA competition – substitute lecturer – ranking 3rd overall and 1st in the quota system for the Department of Life Sciences II – UNEB (State University of Bahia) for the subject of Mechanism of Aggression and Defense (Physiopathology). He was the coordinator of the biomedicine course at the Faculty of Technology and Science – FTC of Jequié, Bahia, from 2017 to 2018. He holds a degree in Biological Sciences, Medical Modality (Biomedicine), from the Hermino Ometto Foundation – Uniararas, São Paulo. He holds a Master's degree in Experimental Pathology from the Ribeirão Preto Medical School, University of São Paulo (FMRP-USP). He completed his doctorate in the Department of Toxicology at the Ribeirão Preto Faculty of Pharmaceutical Sciences - USP (FCRP-USP) with a sandwich period at King's College London (KCL) in the Neurodegenerative Disease Research Group of the Institute of Pharmaceutical Science - Hodgekin Building, Guy's Campus - London. He has completed numerous courses on the use of animals for research at King's College London and USP, which qualified him to work with rats, mice (transgenic and non-transgenic), hamsters, and rabbits. He completed his Post-Doctorate at the Institute of Biosciences - Department of Genetics and Evolutionary Biology - Laboratory of Molecular Neurodegeneration at the University of São Paulo, with the work entitled: "Evaluation of the effect of caffeic acid phenethyl ester (CAPE) on the turnover of connexins 43 and 32 and the possible relationships between gap junctions and propagation of alpha-synuclein aggregates in in-vivo and in-vitro (3D) experimental models of Parkinson's Disease". Therefore, his main research focus is in neuroscience (neuropharmacology). He studies the molecular mechanisms of neurodegenerative diseases, specifically Parkinson's disease, and evaluates the effects of new therapeutic agents on these conditions. During his undergraduate studies, he conducted Scientific Initiation in the area of ??Tissue Repair in the Department of Physiology at Uniararas and, additionally, research in the area of ??molecular pathology, studying the etiopathogenic aspects of melanoma at the University of Western Paulista (UNOESTE). During her master's degree, she completed a collaborative internship in the immunochemistry and glycobiology laboratory of the Department of Cellular-Molecular Biology and Biopathogenic Agents at the Ribeirão Preto Medical School - USP. She has experience in in-vivo and in-vitro experimental models of Parkinson's disease, other neurodegenerative conditions and/or other pathological conditions, and has experience in molecular biology and biochemistry.in ultrastructural, histopathological and confocal microscopy analyses. During her postdoctoral studies, she was supervised by Dr. Merari de Fátima Ramires Ferrari. Currently, she teaches Pharmacology at Bahiana University in the medical program. She has previously taught Scientific Research Methodology II, Psychopharmacology for the medical program at Unifacs, and Clinical-Pathological Interactions and Biosystems for the nursing program at the University of Salvador (Unifacs), in addition to being a Medical English instructor for the medical program at UNIME in Lauro de Freitas - BA. She has experience in Pathology, physiopathology, immunopathology, basic and clinical pharmacology, basic and clinical research, and the development of experimental models for in vivo and in vitro studies.

Research Interest

Neuroscience,  Parkinson's disease, Neurodegenerative diseases,